Evidence map›Paper›PMID 40402077›Full record

ArticleHealth services research2025

Telehealth Use by Home Health Agencies Before, During, and After COVID-19.

Dana B Mukamel, Debra Saliba, Heather Ladd, Melissa A Clark, Michelle L Rogers, Cheryl Meyer Nelson, Marisa L Roczen, Dara H Sorkin, Jacqueline S Zinn, Peter Huckfeldt

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dana B MukameliTEQC Research Program, Department of Medicine, Division of General Internal Medicine, University of California-Irvine, Irvine, California, USA.ORCID https://orcid.org/0000-0003-4147-5785
Debra SalibaUCLA Borun Center at David Geffen School of Medicine, Los Angeles, California, USA.
Heather LaddiTEQC Research Program, Department of Medicine, Division of General Internal Medicine, University of California-Irvine, Irvine, California, USA.
Melissa A ClarkBrown University School of Public Health, Providence, Rhode Island, USA.
Michelle L RogersSurvey Research Center, Brown University School of Public Health, Providence, Rhode Island, USA.
Cheryl Meyer NelsonHealthcare Technology and Direct Healthcare Service Industries, Scituate, Massachusetts, USA.
Marisa L RoczenAbt Associates, Rockville, Maryland, USA.
Dara H SorkiniTEQC Research Program, Department of Medicine, Division of General Internal Medicine, University of California-Irvine, Irvine, California, USA.
Jacqueline S ZinnFox School of Business, Temple University, Philadelphia, Pennsylvania, USA.
Peter HuckfeldtDivision of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, Minnesota, USA.ORCID https://orcid.org/0000-0003-1593-4167

Funding

Home Health, ADRD, Telehealth, and Patient OutcomesR01AG078840 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI MUKAMEL, DANA B · 2022 to 2025
$2.8M
NIA NIH HHS R01 AG078840NIA NIH HHS R01AG078840
6 · The paper itself

Abstract

objectiveTo examine telehealth adoption and discontinuation by home health agencies (HHAs) during the COVID-19 pandemic in the context of telehealth pre-pandemic diffusion into the industry and its continued use once the pandemic abated. STUDY SETTING AND

designHHAs nationally, serving the most patients with dementia (averaging 33% of the agency's patients) were surveyed during October 2023 to November 2024. Key variables included the agency's adoption and discontinuation of specific telehealth technologies by year, the reasons for discontinuation, and the reasons for not adopting any telehealth technology, either before or during the pandemic. DATA SOURCES AND ANALYTIC SAMPLE: Data were collected via a web-based survey with telephone follow-ups. We received 791 responses (37% response-rate) and provide descriptive statistics of responses and graphics. PRINCIPAL

findingsBy 2019, prior to COVID-19, 183 (23%) of HHAs used telehealth, increasing to 446 (56%) by 2021. Growth occurred mainly in virtual visits. Of those HHAs adopting telehealth, 96 (19%) discontinued use later in the pandemic. Key concerns were about the appropriateness of the patient population and reimbursement.

conclusionsPatterns of adoption and discontinuation suggest that COVID-19 interrupted the innovation diffusion process of telehealth into home health. Telehealth's future will depend on information about cost-effectiveness and Medicare reimbursement policies.

Indexed as

COVID-19Home Care AgenciesHome Care ServicesTelemedicineFemaleHumansMaleSARS-CoV-2United StatesCOVID‐19home healthlong‐term carepaymenttechnology diffusiontelehealth

Identifiers

PMID40402077
PMCPMC12461112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.